Literature DB >> 9015038

Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis.

D C Foster1, J D Hasday.   

Abstract

OBJECTIVE: To compare levels of two inflammatory cytokines, interleukin-1 beta(IL-1 beta) and tumor necrosis factor-alpha(TNF-alpha), in selected regions of the vulva, vestibule, and vagina in women with vulvar vestibulitis and in asymptomatic controls.
METHODS: Selective samplings of surgical specimens from 12 women undergoing perineoplasty for vulvar vestibulitis and ten pain-free subjects undergoing posterior vaginal repair were prepared into tissue homogenates and analyzed for concentrations of IL-1 beta and TNF-alpha. Interleukin-1 beta and TNF-alpha concentrations were measured by sandwich enzyme-linked immunosorbent assay. The results were reported after adjustment for total tissue protein concentration.
RESULTS: Median tissue levels of IL-1 beta and TNF-alpha were elevated 2.3-fold and 1.8-fold, respectively, in women with vulvar vestibulitis relative to pain-free women. Median IL-1 beta tissue levels were increased significantly from 1.3 pg/mg to 3.0 pg/mg total protein in women with vulvar vestibulitis compared to pain-free women. Median TNF-alpha tissue levels were increased from 83 pg/mg to 148 pg/mg total protein in women with vulvar vestibulitis compared to pain-free women. Analysis by selected anatomic site of women with vulvar vestibulitis revealed a significant 2.2-fold higher median level of TNF alpha at the vulvar site compared to the vestibule.
CONCLUSION: Concentrations of IL-1 beta and TNF-alpha were elevated in women with vulvar vestibulitis relative to those in asymptomatic controls. This elevation in inflammatory cytokines with vulvar vestibulitis varied according to anatomic site and was, paradoxically, lowest in the area of highest hyperalgesia, the vulvar vestibule. Inflammatory cytokine elevation may contribute to the pathophysiology of mucocutaneous hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015038     DOI: 10.1016/S0029-7844(96)00447-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Vulvar Vestibulitis Syndrome: A Post-infectious Entity?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Dorota Piekna-Przybylska; Sanjay B Maggirwar; Constantine G Haidaris; Richard P Phipps
Journal:  J Low Genit Tract Dis       Date:  2018-01       Impact factor: 1.925

Review 3.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

4.  Differences in primary compared with secondary vestibulodynia by immunohistochemistry.

Authors:  Catherine M Leclair; Martha F Goetsch; Veselina B Korcheva; Ross Anderson; Dawn Peters; Terry K Morgan
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

5.  Innate Immune System Gene Polymorphisms in Women with Vulvovaginal Infections.

Authors:  Mehmet R Genç; Andrew Onderdonk; Steven S Witkin
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

6.  The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes.

Authors:  Sota Omoigui
Journal:  Med Hypotheses       Date:  2007-08-28       Impact factor: 1.538

7.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

Review 8.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

9.  Vulvar vestibulitis syndrome.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.663

Review 10.  Localized Provoked Vulvodynia-An Ignored Vulvar Pain Syndrome.

Authors:  Jorma Paavonen; David A Eschenbach
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.